SCHEMBL4686133

SCHEMBL4686133

COc1cc(CC([NH])=O)cc(Br)c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
APOBEC3A P31941 1/20 0.51
HTT P42858 1/20 0.51
APOBEC3G Q9HC16 1/20 0.51
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA4 P22748 3/20 0.48
CA6 P23280 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.44
THRB P10828 1/20 0.44
TNFRSF1A P19438 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4683243 0.88 KDM4E (0.55) SMN1; SMN2LMNAKDM4EALDH1A1CYP1A2
SCHEMBL4686135 0.84 TSHR (0.59) TSHRALOX15HSD17B10APOBEC3AHTT
SCHEMBL13403398 0.78 CYP1A2 (0.52) TSHRALOX15HSD17B10APOBEC3AHTT
SCHEMBL31681735 0.78 HSD17B10 (0.67) TSHRALOX15HSD17B10APOBEC3AHTT
SCHEMBL3364921 0.78 HSD17B10 (0.67) TSHRALOX15HSD17B10APOBEC3AHTT
SCHEMBL8434037 0.75 PTGS2 (0.73) TSHRALOX15HSD17B10APOBEC3AHTT
SCHEMBL7220499 0.74 THRB (0.69) TSHRALOX15HSD17B10THRB
SCHEMBL14660522 0.74 CA2 (0.50) TSHRALOX15HSD17B10APOBEC3AHTT
SCHEMBL4240508 0.74 PTGS2 (0.53) TSHRALOX15HSD17B10SMN1; SMN2LMNA
SCHEMBL6180121 0.74 CA2 (0.50) TSHRALOX15HSD17B10APOBEC3AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902717-A2 Vasopressin antagonist and oxytocin antagonist Otsuka Pharmaceutical Company, Limited (JP) 2008-03-26 EP disclosed
EP-0620003-B1 VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST OTSUKA PHARMA CO LTD (JP) 2008-01-16 EP disclosed
US-5753644-A Vasopressin antagonist and oxytocin antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-05-19 US disclosed
US-5622947-A VASODILATORS, HYPOTENSIVE AGENTS, DIURETICS, PLATELET AGGLUTINATION INHIBITORS; ALSO USED TO PREVENT PREMATURE BIRTH, TREAT DYSMENORRHEA OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-04-22 US disclosed
EP-0514667-B1 Benzazepin derivatives as vasopressin antagonists OTSUKA PHARMA CO LTD (JP) 1995-08-09 EP disclosed
EP-0620003-A1 VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-19 EP disclosed
US-5244898-A Vasopressin antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-09-14 US disclosed
EP-0514667-A1 Benzazepin derivatives as vasopressin antagonists OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-25 EP disclosed